Incontinentia pigmenti: Clinical and neuroimaging findings in a series of 12 patients;Incontinentia pigmenti. Hallazgos clínicos y radiológicos en una serie de 12 pacientes

Neurologia

Volumn 21, Issue 5, 2006, Pages 239-248

  Pascual Castroviejo, Ignacio ^a,c   Pascual Pascual, S I ^a   Velazquez Fragua R ^a   Martinez V ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Sanatorio Ntra Sra del Rosario   (Spain)

^c NONE   (Spain)

Author keywords

Cerebral changes; Incontinentia pigmenti; Microcephaly; Ocular lesions; Phakomatosis

Indexed keywords

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EYE DISEASE; FEMALE; FOLLOW UP; HEMISPHERE; HUMAN; INCONTINENTIA PIGMENTI; MICROCEPHALY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRESCHOOL CHILD; SCALP; SKIN BIOPSY; SKIN DEFECT;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; BRAIN; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCONTINENTIA PIGMENTI; INFANT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 33745941173     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Garrod AE. Peculiar pigmentation of the skin in an infant. Trans Clin Soc London 1906;39:216-7.
2. Bloch B. Eigentumliche bisher nicht beschriebene pigmentafektion (incontinentia pigmenti). Schweiz Med Wochen 1926;7: 404-5.
3. Sulzberger MB. Über eine bisher micht beschrieben congenitale pigmentonomalie (incontinentia pigmenti). Arch Derm Syph (Berlin) 1928;154:19-32.
4. Pascual-Castroviejo I. Hypomelanosis of Ito. En: Roach ES, Miller VS, editores. Neurocutaneous disorders. Cambridge: Cambridge University Press, 2004; p. 123-30.
5. Franceschetti A, Jadassohn W. A propos de l'incontinentia pigmenti: delimitation de deux sindromes diferentes figurant sous le même terne. Dermatólogica 1954;108:1-28.
6. Carney RG. Incontinentia pigmenti: a world statistical análisis. Arch Dermatol 1976;112:535-42.
7. Morgan JD. Incontinentia pigmenti (Bloch-Sulzberger syndrome): report of four additional cases. Am J dis Child 1971;122:294-300.
8. The International Incontinentia Pigmenti (IP) Consortium. Genomic rearragtement in MEMO impairs NF-kB activation and is a cause of incontinentia pigmenti. Nature 2000;405:466-72.
9. Pascual-Castroviejo I, Roche MC, Martinez Fernández V, Pérez-Romero M, Escudero RM, García-Peñas JJ, et al. Incontinentia pigmenti: MR demonstrations of brain changes. Am J Neuroradiol 1994;15:1521-7.
10. Wiley HE, Frias JL. Depigmented lesions in incontinentia pigmenti: a useful diagnostic sign. Am J Dis Child 1974;128:546-7.
11. Shuper A, Bryan RN, Singer HS. Destructive encephalopathy in incontinentia pigmenti: a primary disorder? Pediatr Neurol 1990;6:137-40.
12. Mangano S, Barbagallo A. Incontinentia pigmenti: clinical and neuroradiological features. Brain Dev 1993;15:362-6.
13. Pörksen G, Pfeiffer C, Hahn G, Poppe M, Friebel D, Kreuz F, et al. Neonatal seizures in two sisters with incontinentia pigmenti. Neuropediatrics 2004;35:139-42.
14. Wolf NI, Krämer N, Harting I, Seitz A, Ebinger F, Poschl J, et al. Diffuse cortical necrosis in a neonate with incontinentia pigmenti and a encephalitis like presentation. Am J Neuroradiol 2005;26:1580-2.
15. O'Doherty NY, Norman RM. Incontinentia pigmenti (Bloch-Sulzberger syndrome) with cerebral malformation. Dev Med Child Neurol 1968;10:372-4.
16. Frontera Izquierdo P, Cabezuelo Huerta G, Mulas F, Monfort Marti A. Afectación neurológica en la incontinentia pigmenti (sindrome de Bloch-Sulzberger). Estudio de tres casos. An Esp Pediatr 1981;14:272-8.
17. Super A, Bryan RN, Singer HS. Destructive encephalopathy in incontinentia pigmenti: a primary disorder? Pediatr Neurol 1990; 6:137-40.
18. Triki C, Devistor D, Kah S, Roge-Wolter M, Lacroix C, Venencie PY, et al. Complications cerebrales de l'incontinentia pigmenti. Etude clinique et pathologique d'un cas. Rev Neurol (Paris) 1992;148:773-6.
19. Brunquell PJ. Recurrent encephalomyelitis associated with incontinentia pigmenti. Pediatr Neurol 1987;3:174-7.
20. Siemes H, Sneider H, Dening D, Hanefeld F. Encephalitis in two members of a family with incontinentia pigmenti (Bloch-Sulzberger syndrome): the possible role of the inflammation in the pathogenesis of CNS involvement. Eur J Pediatr 1978;129:103-15.
21. Avrahami E, Harel S, Jurgenson U, Conn DF. Computed tomographic demonstration of brain changes in incontinentia pigmenti. Am J Dis Child 1985;139:372-4.
22. Stitt WZ, Scott GA, Caserta M, Goldsmith LA. Coexistence of incontinentia pigmenti and neonatal herpes simplex virus infection. Pediatr Dermatol 1998;15:112-5.
23. Fromer ES, Lynch PJ. Neonatal herpes simplex and incontinentia pigmenti. Pediatr Dermatol 2001;18:86.
24. Pellegrino RJ, Shah AJ. Vascular occlusion associated with incontinentia pigmenti. Pediatr Neurol 1994;10:73-4.
25. Fiorillo L, Sinclair DB, O'Byrne ML, Krol AL. Bilateral cerebrovascular accidents in incontinentia pigmenti. Pediatr Neurol 2003; 29:66-8.
26. Hennel SJ, Ekert PG, Volpe JJ, Inder TE. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr Neurol 2003;29:148-50.
27. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50:553-62.
28. Goldberg MF, Custis PH. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology 1993;100:1645-54.
29. François J. Incontinentia pigmenti (Bloch-Sulzberger syndrome). Br J Ophthalmol 1984;68:19-25.
30. Mascaró JM, Palou J, Vives P. Painful subungueal keratotic tumors in incontinentia pigmenti. J Am Acad Dermatol 1985;13: 913-8.
31. Smahi A, Hyden-Granskog C, Peterlin B, Vabres P, Henertz S, Fulchignoni-Letaud MC. The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq29. Hum Mol Genet 1994;3:273-8.
32. Jin DY, Jeang KT. Isolation of full-length cONA and chromosomal localization of human NF-kappa B modulator NEMO to Xq28. J Biomed Sci 1999;6:115-20.
33. Mansour S, Woffendin H, Mitton S, Jeffery I, Jakins T, Kenwrick E, et al. Incontinentia pigmenti in a surviving male is accompanied by hypohydrotic ectodermal dysplasia and recurrent infection. Am J Med Genet 2001;99:172-7.
34. Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-y is an essential regulatori subunit of the Ikb Kinase complex. Nature 1998;395: 297-300.
35. Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, et al. A novel X-linked disorder of immune deficiency and hypohydrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutation in IKK-gamma (NEMO). Am J Hum Genet 2000;67:1555-62.
36. Aradhya S, Courtois G, Raikovic A, Lewis RA, Levy M, Israël A, et al. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-y). Am J Hum Genet 2001;68:765-71.